We are experiencing a new wave of innovation in health care – one that promises to create the smartest, most connected, and most efficient health systems the world has ever seen. Game-changing new technologies and treatments are transforming the practice of medicine, dramatically altering the patient experience, and creating conditions for even more breakthroughs.
The proof is in the data. Last year, a record 61 drugs were introduced worldwide, compared with an annual average of 34 in the previous decade. More than 40% of these treatments were for rare or difficult-to-treat conditions, including hepatitis C, meningococcal B, and metastatic melanoma. And more new breakthroughs are on the horizon. It is estimated that about 70% of the drugs currently in development across the industry are potential “first in class” treatments, meaning that they use a completely new mechanism of action against disease.